vs
Side-by-side financial comparison of MERCANTILE BANK CORP (MBWM) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
MERCANTILE BANK CORP is the larger business by last-quarter revenue ($67.6M vs $37.2M, roughly 1.8× Organogenesis Holdings Inc.). Over the past eight quarters, MERCANTILE BANK CORP's revenue compounded faster (9.1% CAGR vs -46.5%).
Tamilnad Mercantile Bank Limited (TMB) is an Indian bank headquartered at Thoothukudi, Tamil Nadu. TMB was founded in 1921 as the Nadar Bank, but changed its name to Tamilnad Mercantile Bank in November 1962 to widen its appeal beyond the Nadar community. The bank currently has 600 full branches throughout India, 12 regional offices and two link offices, two central processing centres, one service branch, four currency chests, 48 eLobby centres, 262 cash recycler machines and 1151 automated ...
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
MBWM vs ORGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $67.6M | $37.2M |
| Net Profit | $22.7M | — |
| Gross Margin | — | 30.8% |
| Operating Margin | — | -185.1% |
| Net Margin | 33.6% | — |
| Revenue YoY | — | -57.1% |
| Net Profit YoY | 16.1% | — |
| EPS (diluted) | $1.32 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $67.6M | $37.2M | ||
| Q4 25 | $62.1M | $225.6M | ||
| Q3 25 | $62.4M | $150.9M | ||
| Q2 25 | $60.9M | $101.0M | ||
| Q1 25 | $57.3M | $86.7M | ||
| Q4 24 | $58.5M | $126.7M | ||
| Q3 24 | $58.0M | $115.2M | ||
| Q2 24 | $56.8M | $130.2M |
| Q1 26 | $22.7M | — | ||
| Q4 25 | $22.8M | $43.7M | ||
| Q3 25 | $23.8M | $21.6M | ||
| Q2 25 | $22.6M | $-9.4M | ||
| Q1 25 | $19.5M | $-18.8M | ||
| Q4 24 | $19.6M | $7.7M | ||
| Q3 24 | $19.6M | $12.3M | ||
| Q2 24 | $18.8M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% |
| Q1 26 | — | -185.1% | ||
| Q4 25 | 42.0% | 28.1% | ||
| Q3 25 | 44.0% | 13.7% | ||
| Q2 25 | 42.6% | -12.5% | ||
| Q1 25 | 42.0% | -30.9% | ||
| Q4 24 | 39.7% | 8.1% | ||
| Q3 24 | 42.4% | 5.4% | ||
| Q2 24 | 41.4% | -10.7% |
| Q1 26 | 33.6% | — | ||
| Q4 25 | 36.8% | 19.4% | ||
| Q3 25 | 38.1% | 14.3% | ||
| Q2 25 | 37.1% | -9.3% | ||
| Q1 25 | 34.1% | -21.7% | ||
| Q4 24 | 33.5% | 6.1% | ||
| Q3 24 | 33.8% | 10.7% | ||
| Q2 24 | 33.1% | -13.1% |
| Q1 26 | $1.32 | — | ||
| Q4 25 | $1.41 | $0.31 | ||
| Q3 25 | $1.46 | $0.11 | ||
| Q2 25 | $1.39 | $-0.10 | ||
| Q1 25 | $1.21 | $-0.17 | ||
| Q4 24 | $1.20 | $0.05 | ||
| Q3 24 | $1.22 | $0.09 | ||
| Q2 24 | $1.17 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $91.4M |
| Total DebtLower is stronger | $1.5M | — |
| Stockholders' EquityBook value | $736.9M | — |
| Total Assets | $6.9B | $520.0M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $91.4M | ||
| Q4 25 | — | $93.7M | ||
| Q3 25 | — | $63.7M | ||
| Q2 25 | — | $73.1M | ||
| Q1 25 | — | $110.0M | ||
| Q4 24 | — | $135.6M | ||
| Q3 24 | — | $94.3M | ||
| Q2 24 | — | $89.9M |
| Q1 26 | $1.5M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
| Q1 26 | $736.9M | — | ||
| Q4 25 | $724.9M | $300.1M | ||
| Q3 25 | $657.6M | $255.1M | ||
| Q2 25 | $631.5M | $233.2M | ||
| Q1 25 | $608.3M | $242.9M | ||
| Q4 24 | $584.5M | $262.9M | ||
| Q3 24 | $583.3M | $278.5M | ||
| Q2 24 | $551.2M | $263.5M |
| Q1 26 | $6.9B | $520.0M | ||
| Q4 25 | $6.8B | $598.7M | ||
| Q3 25 | $6.3B | $509.8M | ||
| Q2 25 | $6.2B | $461.1M | ||
| Q1 25 | $6.1B | $467.4M | ||
| Q4 24 | $6.1B | $497.9M | ||
| Q3 24 | $5.9B | $446.3M | ||
| Q2 24 | $5.6B | $443.2M |
| Q1 26 | 0.00× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
ORGO
Segment breakdown not available.
